Maynard Um
-
-
-
-
-
-
-
Barclays: Life science insiders sold $187M in stock during first quarter
-
-
-
-
-
-
-
Quest Diagnostics (DGX) PT Lowered to $210 at Evercore ISI, added to TAP list
-
-
-
-
-
-
-
Barclays Upgrades Quest Diagnostics (DGX) to Overweight
-
-
-
-
-
-
-
Quest Diagnostics launches pharmacogenomics testing service
-
-
-
-
-
-
-
Quest Diagnostics (DGX) PT Raised to $190 at JPMorgan
-
-
-
-
-
-
-
Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year
-
-
-
-
-
-
-
Leerink Partners Upgrades Quest Diagnostics (DGX) to Outperform
-
430,727 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

